Companion Diagnostics Market by Application, Technology & End-User - 2019

MarketsandMarkets Presents

Companion Diagnostics Market worth $8,730.7 Million by 2019 http://www.marketsandmarkets.com/Market-Reports/companion-diagnostics-market155571681.html

This market is segmented by technology, application, and end user. Technologies are further subsegmented into immunohistochemistry, in situ hybridization (fluoroscent ISH and chromogenic ISH), polymerase chain reaction (PCR), and next-generation sequencing (NGS)-based tests. The application market is further subsegmented into breast cancer, lung cancer, melanoma cancer, and colorectal cancer. The end users are majorly segmented into pharmaceutical companies and reference laboratories. Among technologies, the polymerase chain reaction (PCR)-based test accounted for the largest share of 65.5% in 2013. The growth of companion diagnostic in the other applications segment (neurological diseases, infectious diseases, ovarian cancer, and leukemia) is expected to grow at a CAGR of 30.3%; whereas, on the basis of end user, reference laboratories is expected to grow at the fastest rate in the market.

Request for Customization: http://www.marketsandmarkets.com/requestCustomization.asp?id=155571681 Browse: • 57 Market Data Tables • 36 Figures • 142 Pages http://www.marketsandmarkets.com/Market-Reports/companion-diagnostics-market155571681.html

The major application driving the global companion diagnostics market is the adoption of companion diagnostic tests in oncology for various indications and for target therapies.

Currently, breast, lung colorectal, and melanoma are the major types of cancer for which FDA approved companion diagnostics are available. In addition, encouragement by regulatory bodies and acceptance of tests by end users are the prominent factors for growth of market. Notable restraining factors include varied reimbursement procedures in different regions and usage of non-validated tests for identification of biomarkers.

However, advanced technologies such as next-generation sequencing and growth of companion diagnostic in prostate cancer, leukemia, ovarian cancer, Alzheimer’s disease, and Parkinson’s disease are likely to augment the global companion diagnostic market in the future.

Speak to Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=155571681

http://www.marketsandmarkets.com/Market-Reports/companion-diagnostics-market155571681.html

In 2013, Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Agilent Technologies (U.S.), QIAGEN N.V. (Netherlands), and Thermo Fisher Scientific Inc. (U.S.) together accounted for a share of 86% of the global companion diagnostics market.

Buy Now: http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=155571681

Scope of the Report

By Technology

By Application

By End User

By Geography

http://www.marketsandmarkets.com/Market-Reports/companion-diagnostics-market155571681.html

About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

http://www.marketsandmarkets.com/Market-Reports/companion-diagnostics-market155571681.html

Contact Us Mr. Rohan North - Dominion Plaza, 17304 Preston Road, Suite 800, Dallas, TX 75252 Tel: +1-888-6006-441 Email: sales@marketsandmarkets.com MarketsandMarkets Blog http://www.marketsandmarkets.com http://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets